Researcher.Life Logo

Acta Haematologica : Impact Factor & More

eISSN: 1421-9662pISSN: 0001-5792

Key Metrics

CiteScore
3.7
H-Index
60
Impact Factor
< 5
SJR
Q2Hematology
SNIP
0.92
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Acta Haematologica

Acta Haematologica Journal Specifications

Overview
Publisher KARGER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1948
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Acta Haematologica ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Acta Haematologica

Treatment Decision-making for Individuals with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the United States.
  • 7 May 2026
  • Acta haematologica
Diagnostic Pathways and Procedural Risk in Primary Central Nervous System Lymphoma: A Nationwide Analysis.
  • 4 May 2026
  • Acta haematologica
A Case Report of Tyrosine Kinase Inhibitor Interruption in a Patient with Multilineage Philadelphia Positive Acute Lymphoblastic Leukemia.
  • 31 Mar 2026
  • Acta haematologica
Chronic Myeloid Leukemia (CML): historical perspective, pathophysiology, and treatment advances.
  • 13 Mar 2026
  • Acta haematologica
Reconsidering Asparaginase in Leukemia Therapy.
  • 13 Mar 2026
  • Acta haematologica
A Complex Case of Anti-e Mimicking Autoantibody Development Leading to Warm Autoimmune Hemolytic Anemia: Case Report
  • 13 Mar 2026
  • Acta Haematologica
Treatment Decision-making for Individuals with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the United States.
  • 7 May 2026
  • Acta haematologica
Diagnostic Pathways and Procedural Risk in Primary Central Nervous System Lymphoma: A Nationwide Analysis.
  • 4 May 2026
  • Acta haematologica
A Case Report of Tyrosine Kinase Inhibitor Interruption in a Patient with Multilineage Philadelphia Positive Acute Lymphoblastic Leukemia.
  • 31 Mar 2026
  • Acta haematologica
Chronic Myeloid Leukemia (CML): historical perspective, pathophysiology, and treatment advances.
  • 13 Mar 2026
  • Acta haematologica
Reconsidering Asparaginase in Leukemia Therapy.
  • 13 Mar 2026
  • Acta haematologica
A Complex Case of Anti-e Mimicking Autoantibody Development Leading to Warm Autoimmune Hemolytic Anemia: Case Report
  • 13 Mar 2026
  • Acta Haematologica

FAQs on Acta Haematologica